Turn Therapeutics (TTRX) Change in Accured Expenses (2024 - 2026)

Turn Therapeutics' Change in Accured Expenses history runs 3 years deep, the most recent figure standing at -$613464.0 for Q1 2026.

• On a quarterly basis, Change in Accured Expenses fell 2853.75% year-over-year to -$613464.0 in Q1 2026; TTM through Mar 2026 was $80654.0, a N/A change from a year earlier, with the FY2025 full-year figure at $2.3 million, up 1015.95% from the prior year.
• Change in Accured Expenses declined to -$613464.0 in Q1 2026 per TTRX's latest filing, from $664303.0 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $664303.0 in Q4 2025 and bottomed at -$613464.0 in Q1 2026.
• The 3-year median for Change in Accured Expenses is $14907.5 (2024), against an average of $20163.5.
• Across the five-year window, Change in Accured Expenses jumped 1213.27% in 2025 and tumbled 2853.75% in 2026, its largest moves.
• Year by year, Change in Accured Expenses stood at $50584.0 in 2024, then soared by 1213.27% to $664303.0 in 2025, then sank by 192.35% to -$613464.0 in 2026.
• Per Business Quant, the three latest TTRX Change in Accured Expenses figures stand at -$613464.0 (Q1 2026), $664303.0 (Q4 2025), and -$20769.0 (Q1 2025).